Clinical Trial Update: LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing low molecular weight heparin versus aspirin for venous thromboembolism prophylaxis in orthopedic oncology, currently enrolling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Bone Sarcoma
• Soft Tissue Sarcoma
• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Sarcoma, Soft Tissue Sarcoma | Phase 4 | Status: ENROLLING_BY_INVITATION